The short answer: the reason most cold emails to biopharma companies fail is not the wording. It is the timing. A well crafted email sent to a company with no reason to act is still deleted. The emails that get replies are tied to a trigger event, a funding round, a clinical readout, a leadership change, that gives the recipient a reason to read. Fix the timing first, then fix the copy.
Below is what separates outreach that books meetings from outreach that gets ignored, and the sequence structure that works when you sell services into life sciences.
Why your biotech cold emails are not working
Senior operators in biopharma receive dozens of vendor emails a week. They have developed a fast, unconscious filter, and they use it to delete on the subject line alone. The three things that trip that filter hardest are:
- A generic opener. “I hope this email finds you well” signals a template, and a template signals that you are emailing a hundred companies.
- A capabilities pitch. Leading with what you do, rather than what they need, puts the burden on the reader to connect the dots. They will not.
- No reason for the timing. If there is no event behind the email, the recipient has no reason to reply today rather than never.
The one thing that changes everything: a trigger
A trigger based email references something specific that just happened to the recipient’s company. It proves you are paying attention, and it gives a concrete reason to talk now.
Compare these two openers:
“I wanted to introduce our clinical trial management services and see if there might be a fit.”
“You just opened enrollment on your Phase 2. In this indication, the sites that actually enroll are a short list, and most sponsors find that out six months in. Want the list now instead?”
The first could go to anyone. The second could only go to one company, this week, and it demonstrates that you understand their exact problem. That is the entire difference.
Six rules for outreach that lands
- Never open with congratulations. The week a company announces good news, it gets thirty congratulatory emails. Congratulations is camouflage. It makes you look like everyone else.
- Lead with their problem, not your service. Name the specific thing their event is about to cost them, in their language.
- Give something away in the second email. A useful resource with no ask attached. A follow up that only says “just following up” teaches the reader your emails are worthless.
- Leave properly. A clean, guilt free breakup email is the reason a buyer calls you six months later when the thing you predicted comes true.
- Be willing to say the answer might be no. “If the numbers do not work, I will tell you they do not work” is the most credible sentence you can send.
- Write like one person to another. If a sentence could appear in a brochure, delete it.
Subject lines that get opened
The formats that survive a senior operator’s filter tend to be short, specific, and free of sales language:
- Short and specific. “IND enabling timeline.” Under five words, reads like an internal note.
- The negation. “Not about the trial.” Violates the expectation set by every other email.
- The date. “Counting backward from March.” Uses the recipient’s own deadline.
- The observation. “It is usually access.” States something true about their situation before saying anything about you.
The formats to avoid: “Quick question,” “Following up,” “Touching base,” “Partnership opportunity.” These are the most deleted subject lines in the industry.
Structure a three email sequence, not a single send
Most replies arrive on the second or third touch, and most teams stop at the first. A working sequence looks like this:
- Email one: the trigger, the consequence, and one specific question they cannot answer without thinking.
- Email two, a few days later: something useful given away with no ask.
- Email three, the following week: a clean exit that leaves the door open.
Then stop. A fourth email costs you the account and gains you nothing.
Frequently asked questions
What is the best cold email strategy for selling to pharma?
Tie every email to a trigger event at the recipient’s company and lead with the problem that event creates. Trigger based outreach consistently outperforms generic capabilities pitches because it gives the buyer a reason to reply now.
How many follow ups should a sales email sequence have?
Three. First touch, a value add second touch, and a clean breakup. Most positive replies come on the second or third message, but a fourth touch tends to damage the relationship.
What subject lines work best for B2B life sciences outreach?
Short, specific, and free of sales language. Subject lines that read like an internal note or reference a specific event at the recipient’s company outperform anything that sounds like marketing.
Should I congratulate a company on their funding round in a cold email?
No. Congratulating a company on good news makes your email identical to the thirty others they received that week. Reference the specific consequence of the news instead, and what it means they will need next.
Get the full set of sequences
We put together ten complete outreach sequences, thirty emails in total, each built around a specific trigger event, with subject lines, send windows, the exact title to send to, and a breakdown of why each one works.
